Mayne Pharma Group Ltd
(FRA:HG6)
€
2.92
0 (0%)
Market Cap: 247.26 Mil
Enterprise Value: 179.89 Mil
PE Ratio: 0
PB Ratio: 0.89
GF Score: 75/100 Half Year 2021 Mayne Pharma Group Ltd Earnings Presentation Transcript
Feb 23, 2021 / 10:00PM GMT
Release Date Price:
€3.48
(-2.25%)
Operator
Presentation
Feb 23, 2021 / 10:00PM GMT
=====================
Corporate Participants
=====================
* Peter Paltoglou
Mayne Pharma Group Limited - CFO
* Scott Anthony Richards
Mayne Pharma Group Limited - MD, CEO & Executive Director
=====================
Conference Call Participants
=====================
* Gretel Janu
Crédit Suisse AG, Research Division - Research Analyst
* John Deakin-Bell
Citigroup Inc. Exchange Research - Research Analyst
* John Hester
Bell Potter Securities Limited, Research Division - Senior Healthcare Equities Analyst
* Saul Hadassin
UBS Investment Bank, Research Division - Executive Director & Research Analyst
=====================
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot